
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.05 | 0.05 | 0.00 |
Shares | 97.93 | 97.93 | 0.00 |
Other | 2.02 | 2.16 | 0.14 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.67 | 18.92 |
Price to Book | 5.28 | 4.33 |
Price to Sales | 5.07 | 2.37 |
Price to Cash Flow | 15.97 | 15.54 |
Dividend Yield | 1.27 | 1.18 |
5 Years Earnings Growth | 3.14 | 10.49 |
Number of long holdings: 176
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 14.63 | 210.60 | +0.53% | |
Amgen | US0311621009 | 9.43 | 293.72 | -0.69% | |
Gilead | US3755581036 | 8.97 | 114.77 | -1.18% | |
Krystal Biotech | US5011471027 | 6.81 | 150.49 | +3.29% | |
Alnylam | US02043Q1076 | 5.82 | 454.38 | -2.82% | |
Insmed | US4576693075 | 2.76 | 131.88 | -0.54% | |
Ascendis Pharma AS | US04351P1012 | 2.68 | 194.30 | +0.78% | |
argenx ADR | US04016X1019 | 2.43 | 660.00 | -0.56% | |
UCB | BE0003739530 | 2.27 | 197.30 | -0.85% | |
Scholar Rock | US80706P1030 | 1.54 | 35.49 | +2.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 681.82B | 8.58 | 17.09 | 13.65 | ||
Fidelity Contrafund | 160.4B | 15.36 | 26.02 | 15.97 | ||
Fidelity Total Market Index Instl b | 113.87B | 8.09 | 16.45 | 12.97 | ||
Fidelity Blue Chip Growth | 67.4B | 8.95 | 26.27 | 17.98 | ||
Fidelity Growth Company | 64.44B | 9.25 | 25.04 | 18.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review